Scientists have published the results of their research into the action mechanisms of a promising experimental tuberculosis (TB) vaccine. BCG, the only currently approved TB vaccine, has been around for almost a century, but it is only partially effective and the protection it offers fades over time. Given the current emergence of adult TB cases in conjunction with the HIV epidemic and the rise in multidrug-resistant TB strains, the development of a new, more effective vaccine is a global health priority.
- Institut Pasteur
- Support us